Clovis Oncology (CLVS) Reports $200M Convertible Senior Notes Offering
Tweet Send to a Friend
Clovis Oncology, Inc. (Nasdaq: CLVS) announced that, subject to market and other conditions, it intends to offer $200 million aggregate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
